The firm has landed roles on some of the biggest deals of the year, working on the Pfizer-Allergan $160 billion megadeal.
It also has a role on the $20 billion Jarden-Newell Rubbermaid deal announced this week.
The firm has worked on deals worth $464 billion so far this year, and has hauled in more than $500 million in revenue from M&A deals, according to estimates from Dealogic.
To put that into context, Centerview lists 31 partners on its website. That works out at $16.4 million in revenue per partner.
According to various estimates, the boutique has between 200 and 225 employees. Even using the high range of that estimate, it means that on $508 million, Centerview made an average of more than $2.25 million per worker on its mega-M&A year.
Business Insider's Ben Moshinsky revealed details on Centerview's UK business earlier this week. The firm paid its top UK partner an £8 million ($12 million) profit share in 2015, according to its accounts.
Those accounts showed an operating profit of £18.6 on revenues of £26.3 million, giving it an operating margin of 71%. Almost all of that operating profit was paid out to members in compensation.
Centerview ranks #12 for M&A globally
Dealogic
The bank also placed twelfth worldwide for deals revenue